ANI MEININGSIH, NIM. C11700078 (2021) EVALUASI PENGGUNAAN OBAT PADA PASIEN GASTROESOPHAGEAL REFLUX DISEASE (GERD) RAWAT JALAN DI RUMAH SAKIT UMUM PURBOWANGI GOMBONG PERIODE TAHUN 2019-2020. Skripsi thesis, UNIVERSITAS MUHAMMADIYAH GOMBONG.
![[thumbnail of ANI MEININGSIH (C11700078)_compressed.pdf]](/style/images/fileicons/text.png) |
Text
ANI MEININGSIH (C11700078)_compressed.pdf Download (929kB) |
Abstract
Background : Gastroesophageal Reflux Disease (GERD) is a digestive tract disease that attacks the stomach, which is caused by the return of contents from the stomach into the esophagus, with various signs and symptoms such us Heartburn and Regurgitation involving the esophagus, pharynx, larynx and respiratory tract. This disease is often considered a normal disease, but this disease can cause recurrence to death, where if this is left it will cause severity and eventually stomach acid will be injured and ulcers occur which will cause vomiting of blood. One of the treatments for this disease is by offering H2RA drugs, Antacids, Sucralfat and PPIs that are appropriate to ensure the quality and effectiveness of Gastroesophageal Reflux Disease (GERD) therapy which includes the right indication, right patient, right drug and right dose (4 T). Research methods : Non-experimental research with retrospective data collective, total sampling technique and analyzed descriptively. Results : In this study, 81 cases of Gastroesophageal Reflux Disease (GERD) were obtained. the resulting data was then compared with Koda Kimble 2013.The drugs that are often used in the outpatient Pharmacy Installation at Purbowangi General Hospital in 2019-2020 are Lansoperazole 16%, Omeperazole Omeperazole 2 %, Lansoperazole & Sucralfat syr 46 %, Omeperazole & Sucralfat syr 14 %, Lansoperazole & Sucralfat syr & Domperidone 10 %, Omeperazole & Sucralfat syr & Domperidone 2 %, Lansoperazole & Domperidone 2 %, Lansoperazole & Antasida syr & Ranitidine 1 %, Lansoperazole & Antasida syr 2 % and Omeperazole & Antasida syr 1 %. Conclusion : Evaluation of the use of drugs to treat Gastroesophageal Reflux Disease (GERD) is known that is 100% right on the indication, 95% right fot the patient, 85% right on the drug and 33% right on the dose at Purbowangi Gombong General Hospital for the period 2019-2020 Recommendation : The next researcher examines the use of Gastroesophageal Reflux Disease (GERD) drugs in inpatients to monitor the patient’s condition.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | Apt. Tri Cahyani, M.Sc; Apt. Drs. Muh. Husnul Khuluq, M.Farm |
| Uncontrolled Keywords: | Evaluation of drug use, GERD, Proton Pump Inhibitor;Evaluasi Penggunaan Obat, GERD, Proton Pump Inhibitor |
| Subjects: | S1 Farmasi |
| Depositing User: | DWI SUNDARIYATI S.I.Pust |
| Date Deposited: | 26 Mar 2022 02:34 |
| Last Modified: | 26 Mar 2022 02:34 |
| URI: | http://repository.unimugo.ac.id/id/eprint/1696 |
Actions (login required)
 |
View Item |